The Mental Health Among Patients, Providers, and Staff (MHAPPS) Study is designed to study how the COVID-19 pandemic has affected mental health and wellbeing, and how to support mental health while minimizing the burden on the healthcare system. The study will enroll adults and adolescents who have had a primary care visit in the last 12 months, as well as healthcare providers and staff from a large health system in Idaho. The study will include: Aim 1: a cross sectional survey to measure the prevalence of various measures of mental distress and how they are associated with COVID-19-related factors; and Aim 2: a randomized controlled trial comparing the effectiveness of two versions of a Caring Contacts intervention to reduce loneliness and mental distress.
Approximately 4,800 participants will complete the Aim 1 survey. The Caring Contacts
intervention involves sending a series of brief, non-demanding, supportive text messages to
the participant. One intervention arm will receive an introductory phone call and the caring
text messages (CC+); the second intervention arm will only receive the same caring text
messages (CC). The clinical trial will enroll a subset of 660 participants who report
elevated levels of loneliness, suicide ideation, or other mental distress in the Aim 1
survey. Enrollment will be stratified by population (providers and employees; patients) with
165 per intervention arm in each stratum.
The investigators hypothesize that delivering the Caring Contacts intervention with an
introductory phone call will yield better mental health outcomes than delivering the Caring
Contacts intervention with no introductory phone call.
This will be the first published data directly comparing the effectiveness of two versions of
the Caring Contacts intervention with individuals who report loneliness or other mental
distress. The overall goal of the MHAPPS study is to better understand the mental health
impact of COVID-19 and to determine how health systems can most effectively support mental
health at scale among providers, staff, and patients in the COVID-19 era and beyond.
This research is being conducted by a team including health system-based researchers,
clinicians, other frontline healthcare workers, and administrators; academic researchers;
follow-up specialists and administrators at the Idaho Suicide Prevention Hotline, and an
advisory board of people with lived experience with suicide.
Other: Caring Contacts Plus Introductory Phone Call (CC+)
One introductory semi-structured caring phone conversation with a follow-up specialist to check-in, establish a personal connection, and provide resources at the 0-2 week time-point followed by 11 non-demanding, caring text or email messages sent over the course of 6 months.
Other: Caring Contacts without an introductory phone call (CC)
Eleven non-demanding, caring text or email messages sent over the course of 6 months. Participants will not know or have spoken to the follow-up specialist who sends the caring messages.
Inclusion Criteria:
Aim 1:
- Provider & Employee Inclusion Criteria
- Provider or Employee at St. Luke's Health System
- Adults ≥ 18 years of age
- Proficient in spoken and written English language
- Patient Inclusion Criteria
- Patient at a St. Luke's Health System primary care site
- Current MyChart account user
- Adults ≥18 years of age
- Minors 12-17 years of age
- Proficient in spoken and written English language
Aim 2:
- Provider & Employee Inclusion Criteria
- Moderate or high score for loneliness, suicide ideation, psychological stress,
anxiety, or depression:
- NIH Toolkit Loneliness raw score of 13 or greater or
- C-SSRS score of 3 or greater; or
- NIH Toolkit Perceived Stress raw score of 31 or greater for adults; or
- GAD7 score of 11 or greater; or
- PHQ9 score of 10 or greater
- Access to a phone for the duration of the study with the ability to receive text
messages and phone calls
- Patient Inclusion Criteria
- Moderate or high score for loneliness, suicide ideation, psychological stress,
anxiety, or depression:
- NIH Toolkit Loneliness raw score of 13 or greater for adults or 16 or
greater for adolescents; or
- C-SSRS score of 3 or greater; or
- GAD7 score of 11 or greater; or
- PHQ9 score of 10 or greater; or
- NIH Toolkit Stress raw score of 31 or greater for adults or 33 or greater
for adolescents
- [Note: validated youth versions of the NIH Toolkit assessments (loneliness
and perceived stress), and PHQ-A tools will be used for adolescents; the
C-SSRS and GAD7 tools are validated for use with both adults and
adolescents.]
- Access to a phone for the duration of the study with the ability to receive text
messages and phone calls
Exclusion Criteria:
Aim 1:
- Provider & Employee Exclusion Criteria
- Individuals who are unable or unwilling to provide informed consent to
participate
- Individuals who are study staff for this study or the SPARC Trial
- Patient Exclusion Criteria
- Individuals who are unable or unwilling to provide informed consent to
participate.
- Individuals who are participants in the SPARC Trial
- Individuals who have not had a primary care visit in the past 12 months
Aim 2:
- Provider & Employee Exclusion Criteria
- Individuals who are unable or unwilling to provide informed consent to
participate
- Individuals who are in acute crisis as determined by the person conducting the
consent process
- Individuals who are study staff for this study or the SPARC Trial
- Individuals who are enrolled as participants in the SPARC comparative
effectiveness clinical trial (SPARC Aim 1). Providers or employees who received
training related to SPARC and/or who completed the SPARC provider satisfaction
survey are not excluded from participating in MHAPPS
- Patient Exclusion Criteria
- Patients who are unable or unwilling to provide informed consent/assent to
participate (or whose legally authorized representative is unable or unwilling to
provide consent in the case of adolescents). Examples may include but are not
limited to patients who present with acute or chronic cognitive impairment that
would preclude their ability to consent (i.e. acute psychosis, intoxication, or
intellectual disability).
St. Luke's Health System
Boise, Idaho, United States
Anna K Radin, DrPH, MPH, Principal Investigator
St. Luke's Health System